Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The role of γδT-cells in causing alopecia areata remains unclear.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Targeting Vδ1+T-cells may help treat alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Clonally expanded CD8+ T cells cause alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

γδ T cells are essential for wound healing after poxvirus infection.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Immune cells affect hair growth and could lead to new hair loss treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.